Immune-mediated necrotizing myopathy
Also known as: Immune-mediated necrotising myopathy / Immune Mediated Necrotizing Myopathy / Autoimmune necrotizing myopathy (disorder) / Immune-mediated myositis
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB18180 | CT103A | 0 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 0 | Recruiting | 1 |
DB01073 | Fludarabine | 0 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 1 / 2 | Recruiting | 1 |
DB01073 | Fludarabine | 1 / 2 | Recruiting | 1 |
DB00062 | Albumin human | 2 | Withdrawn | 1 |
DB00028 | Human immunoglobulin G | 2 | Recruiting | 1 |
DB00028 | Human immunoglobulin G | 2 | Withdrawn | 1 |
DB09153 | Sodium chloride | 2 | Recruiting | 1 |
DB15636 | Zilucoplan | 2 | Terminated | 1 |